Clinical improvement after surgery for degenerative cervical myelopathy; A comparison of Patient-Reported Outcome Measures during 12-month follow-up.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 06 08 2021
accepted: 18 02 2022
entrez: 8 3 2022
pubmed: 9 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

Although many patients report clinical improvement after surgery due to degenerative cervical myelopathy, the aim of intervention is to stop progression of spinal cord dysfunction. We wanted to provide estimates and assess achievement rates of Minimal Clinically Important Difference (MCID) at 3- and 12-month follow-up for Neck Disability Index (NDI), Numeric Rating Scale for arm pain (NRS-AP) and neck pain (NRS-NP), Euro-Qol (EQ-5D-3L), and European Myelopathy Score (EMS). 614 degenerative cervical myelopathy patients undergoing surgery responded to Patient-Reported Outcome Measures (PROMs) prior to, 3 and 12 months after surgery. External criterion was the Global Perceived Effect Scale (1-7), defining MCID as "slightly better", "much better" and "completely recovered". MCID estimates with highest sensitivity and specificity were calculated by Receiver Operating Curves for change and percentage change scores in the whole sample and in anterior and posterior procedural groups. The NDI and NRS-NP percentage change scores were the most accurate PROMs with a MCID of 16%. The change score for NDI and percentage change scores for NDI, NRS-AP and NRS-NP were slightly higher in the anterior procedure group compared to the posterior procedure group, while remaining PROM estimates were similar across procedure type. The MCID achievement rates at 12-month follow-up ranged from 51% in EMS to 62% in NRS-NP. The NDI and NRS-NP percentage change scores were the most accurate PROMs to measure clinical improvement after surgery for degenerative cervical myelopathy. We recommend using different cut-off estimates for anterior and posterior approach procedures. A MCID achievement rate of 60% or less must be interpreted in the perspective that the main goal of surgery for degenerative cervical myelopathy is to prevent worsening of the condition.

Identifiants

pubmed: 35259164
doi: 10.1371/journal.pone.0264954
pii: PONE-D-21-25531
pmc: PMC8903279
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0264954

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
Eur Spine J. 2006 Jan;15 Suppl 1:S93-108
pubmed: 16320033
Spine (Phila Pa 1976). 2015 Jun 15;40(12):E675-93
pubmed: 25839387
BMC Musculoskelet Disord. 2019 Jan 18;20(1):31
pubmed: 30658613
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Control Clin Trials. 1989 Dec;10(4):407-15
pubmed: 2691207
Health Econ. 1996 Mar-Apr;5(2):141-54
pubmed: 8733106
Spine J. 2010 Jun;10(6):469-74
pubmed: 20359958
J Bone Joint Surg Am. 2016 Mar 2;98(5):370-8
pubmed: 26935459
J Neurosurg Spine. 2019 May 10;31(3):317-325
pubmed: 31075769
Eur Spine J. 2016 Jan;25(1):282-286
pubmed: 26208938
BMC Musculoskelet Disord. 2019 Jan 22;20(1):36
pubmed: 30669998
Eur Spine J. 2019 May;28(5):1234-1241
pubmed: 30877386
Spine (Phila Pa 1976). 2020 May 15;45(10):649-656
pubmed: 31809467
Acta Orthop. 2011 Feb;82(1):56-63
pubmed: 21189113
Spine J. 2016 Apr;16(4 Suppl):S12-8
pubmed: 26850172
Qual Life Res. 2007 Feb;16(1):131-42
pubmed: 17033901
Acta Orthop. 2015;86(5):534-44
pubmed: 25909475
J Neurosurg Spine. 2013 Feb;18(2):154-60
pubmed: 23176164
Acta Orthop. 2013 Apr;84(2):196-201
pubmed: 23506164
J Pain. 2008 Feb;9(2):105-21
pubmed: 18055266
J Orthop Sports Phys Ther. 2009 May;39(5):400-17
pubmed: 19521015
Spine (Phila Pa 1976). 2015 Nov;40(21):1653-9
pubmed: 26502097
J Neurosurg Spine. 2017 Jun;26(6):653-667
pubmed: 28304237
Spine (Phila Pa 1976). 2015 Sep 1;40(17):1315-21
pubmed: 26020849
Spine (Phila Pa 1976). 2020 Nov 1;45(21):1485-1490
pubmed: 32796460
Spine (Phila Pa 1976). 2013 Oct 15;38(22 Suppl 1):S173-82
pubmed: 23962995
Spine (Phila Pa 1976). 2019 May 15;44(10):691-697
pubmed: 30395093
Spine (Phila Pa 1976). 2018 Nov 1;43(21):E1260-E1266
pubmed: 29652783
Spine (Phila Pa 1976). 2013 Dec 15;38(26):2247-52
pubmed: 24108289
J Orthop Sci. 2020 Jan;25(1):58-65
pubmed: 30905611
Spine J. 2006 Nov-Dec;6(6 Suppl):299S-307S
pubmed: 17097550
J Clin Epidemiol. 2010 Jul;63(7):760-766.e1
pubmed: 20056385
Eur Spine J. 2017 Oct;26(10):2650-2659
pubmed: 28616747
PLoS One. 2013 Jun 24;8(6):e67408
pubmed: 23826290
Spine J. 2020 Sep;20(9):1413-1421
pubmed: 32502657
Clin Spine Surg. 2019 Nov;32(9):392-397
pubmed: 31569175
J Bone Joint Surg Am. 2013 Sep 18;95(18):1651-8
pubmed: 24048552
Stat Med. 1989 Oct;8(10):1183-90
pubmed: 2682909
Spine (Phila Pa 1976). 2013 Oct 15;38(22 Suppl 1):S55-67
pubmed: 23963006
Qual Life Res. 2018 May;27(5):1159-1170
pubmed: 29550964
Spine (Phila Pa 1976). 2015 Sep 1;40(17):1322-8
pubmed: 26020847

Auteurs

Christer Mjåset (C)

Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.

John-Anker Zwart (JA)

Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.

Frode Kolstad (F)

Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.

Tore Solberg (T)

Institute of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.
Department of Neurosurgery, The University Hospital of North Norway, Tromsø, Norway.
The Norwegian Registry for Spine Surgery, The University Hospital of North Norway, Tromsø, Norway.

Margreth Grotle (M)

Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
Department of Physiotherapy, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH